Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentchromatin

BUD31 ZBED1 DMRTB1 TCF7L2 CHEK1 BRD1

7.81e-041480176GO:0000785
GeneOntologyCellularComponentPML body

ZBED1 TCF7L2

4.55e-03125172GO:0016605
GeneOntologyCellularComponentnuclear body

ZBED1 TCF7L2 HCFC2 BRD1

5.24e-03903174GO:0016604
DomainRNaseH-like_dom

ZBED1 ERI2

1.98e-0369182IPR012337
Pubmed

Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.

EDN1 TCF7L2

7.59e-07318216291872
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

BUD31 ZMYM3 TCF7L2 BRD1

2.33e-0460818436089195
Pubmed

Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.

EDN1 CHEK1

4.55e-046118227694478
ToppCellE16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CDC42BPB EDN1 ANKEF1

4.15e-05170183af8b56555cbd5a1016ab9ec2ce88225c58c89648
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIAS CHEK1 ERI2

5.08e-05182183fe46819c153a81911864473badc794f243705f98
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIAS CHEK1 ERI2

5.08e-051821833948422707d6d5e021bcd7158e2eb69143613f62
ToppCellBAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDIAS CDC42BPB TCF7L2

6.43e-0519718333f2fe101ae5744eea3915add37e60aa398bb97f
ToppCellBAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DDIAS CDC42BPB TCF7L2

6.43e-05197183d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0
ToppCellBAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DDIAS CDC42BPB TCF7L2

6.43e-051971839262785807faeb32417fad7ef202405053e453e2
ToppCellBAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDIAS CDC42BPB TCF7L2

6.43e-051971835e9a3932ae5147a3d73dc70f1545926a692930ed
ToppCellSevere_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

DDIAS CDC42BPB TCF7L2

6.43e-051971838a126cfe1529f3d75a806aa492743314a8a43ef9
Drug4,4'-DBP

ZBED1 TCF7L2

1.00e-0419182CID000007034
DrugAC1NRAEN

EDN1 BRD1

2.53e-0430182CID005287841
DrugHelveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

EDN1 TCF7L2 HCFC2

2.82e-041651833851_UP
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A

EDN1 TCF7L2 HCFC2

2.87e-041661835324_UP
DrugGSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A

ANKEF1 TCF7L2 TSTD2

4.13e-041881837097_DN
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A

CDC42BPB TCF7L2 HCFC2

4.52e-041941834572_DN
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A

TCF7L2 CHEK1 BRD1

4.59e-041951832125_DN
Drugfluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

ZMYM3 TCF7L2 HCFC2

4.66e-041961836954_DN
DrugSyrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A

TCF7L2 CHEK1 BRD1

4.80e-041981831761_DN
DrugArtemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

CDC42BPB ANKEF1 TCF7L2

4.87e-041991837247_DN
DrugAmoxicillin [26787-78-0]; Down 200; 11uM; HL60; HT_HG-U133A

ZMYM3 TCF7L2 HCFC2

4.87e-041991831265_DN
DiseaseNeurodevelopmental Disorders

CDC42BPB TCF7L2

1.30e-0393172C1535926
Diseasepancreatic cancer (is_implicated_in)

TCF7L2 CHEK1

1.87e-03112172DOID:1793 (is_implicated_in)
Diseasetype 2 diabetes mellitus (is_marker_for)

EDN1 TCF7L2

2.74e-03136172DOID:9352 (is_marker_for)
Diseasetype 2 diabetes mellitus (biomarker_via_orthology)

EDN1 TCF7L2

3.19e-03147172DOID:9352 (biomarker_via_orthology)
DiseaseMyocardial Ischemia

EDN1 TCF7L2

4.54e-03176172C0151744

Protein segments in the cluster

PeptideGeneStartEntry
RKCCGYFKWEQTLQK

ERI2

631

A8K979
KWKKQGYENLCCLRC

BUD31

91

P41223
ARWKLTCYLCKQKGV

BRD1

321

O95696
QCLKETCEKLGYQWK

CHEK1

391

O14757
IKKKGTRAYACQCSW

CFAP418

171

Q96NL8
CCKYIAQRGCDLKWK

ANKEF1

266

Q9NU02
YKKALNSQVCCKDLW

HCFC2

336

Q9Y5Z7
LCKLENKQYCRWSKN

DDIAS

606

Q8IXT1
KKGWQRAYAVVCDCK

CDC42BPB

1111

Q9Y5S2
RWKQCLCEKCYLISE

DMRTB1

31

Q96MA1
KKECYEWINTCSCLL

AXDND1

796

Q5T1B0
NWYVKKCLNDVGICK

DEFB126

21

Q9BYW3
ENRCQCASQKDKKCW

EDN1

106

P05305
CASQKDKKCWNFCQA

EDN1

111

P05305
GNKFECDCKAKWLYL

LGI2

166

Q8N0V4
WCGPCRRKKKCVRYI

TCF7L2

476

Q9NQB0
SFECKEKLWKCCRQL

TSTD2

71

Q5T7W7
EGCILQWKKIYCRIC

ZBED1

36

O96006
CKSKYLLWYCKAARC

ZMYM3

706

Q14202